Business Description
Nanoviricides Inc
NAICS : 325412
SIC : 2834
ISIN : US6300872032
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.17 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 33.1 | |||||
3-Year EPS without NRI Growth Rate | 20.3 | |||||
3-Year FCF Growth Rate | 25 | |||||
3-Year Book Growth Rate | -19 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.05 | |||||
9-Day RSI | 60.72 | |||||
14-Day RSI | 61.47 | |||||
6-1 Month Momentum % | 3.55 | |||||
12-1 Month Momentum % | -1.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.32 | |||||
Quick Ratio | 4.32 | |||||
Cash Ratio | 4.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.8 | |||||
Shareholder Yield % | -5.76 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -68.73 | |||||
ROA % | -62.75 | |||||
ROIC % | -118.03 | |||||
ROC (Joel Greenblatt) % | -119.19 | |||||
ROCE % | -65.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.34 | |||||
Price-to-Tangible-Book | 2.42 | |||||
EV-to-EBIT | -2.06 | |||||
EV-to-EBITDA | -2.24 | |||||
EV-to-FCF | -3.05 | |||||
Price-to-Net-Current-Asset-Value | 9.3 | |||||
Price-to-Net-Cash | 10.33 | |||||
Earnings Yield (Greenblatt) % | -48.54 | |||||
FCF Yield % | -25.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nanoviricides Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.757 | ||
Beta | 0.4 | ||
Volatility % | 45.33 | ||
14-Day RSI | 61.47 | ||
14-Day ATR (€) | 0.165152 | ||
20-Day SMA (€) | 1.384 | ||
12-1 Month Momentum % | -1.92 | ||
52-Week Range (€) | 0.9 - 2.18 | ||
Shares Outstanding (Mil) | 11.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanoviricides Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanoviricides Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Nanoviricides Inc Frequently Asked Questions
What is Nanoviricides Inc(STU:NV3P)'s stock price today?
When is next earnings date of Nanoviricides Inc(STU:NV3P)?
Does Nanoviricides Inc(STU:NV3P) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |